JP2002524490A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002524490A5 JP2002524490A5 JP2000569777A JP2000569777A JP2002524490A5 JP 2002524490 A5 JP2002524490 A5 JP 2002524490A5 JP 2000569777 A JP2000569777 A JP 2000569777A JP 2000569777 A JP2000569777 A JP 2000569777A JP 2002524490 A5 JP2002524490 A5 JP 2002524490A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- aerosol foam
- weight
- amount
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 description 23
- 239000000443 aerosol Substances 0.000 description 11
- 239000006260 foam Substances 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 4
- -1 fatty acid salt Chemical class 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229960004311 betamethasone valerate Drugs 0.000 description 1
- SNHRLVCMMWUAJD-SUYDQAKGSA-N betamethasone valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960004703 clobetasol propionate Drugs 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP5831A AUPP583198A0 (en) | 1998-09-11 | 1998-09-11 | Mousse composition |
| PCT/AU1999/000735 WO2000015193A1 (en) | 1998-09-11 | 1999-09-08 | Mousse composition |
| AU5831 | 2000-02-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002524490A JP2002524490A (ja) | 2002-08-06 |
| JP2002524490A5 true JP2002524490A5 (https=) | 2006-11-02 |
| JP4603164B2 JP4603164B2 (ja) | 2010-12-22 |
Family
ID=3810055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000569777A Expired - Lifetime JP4603164B2 (ja) | 1998-09-11 | 1999-09-08 | ムースの組成 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US6730288B1 (https=) |
| EP (2) | EP1112062B1 (https=) |
| JP (1) | JP4603164B2 (https=) |
| AT (1) | ATE381315T1 (https=) |
| AU (2) | AUPP583198A0 (https=) |
| BR (1) | BR9913154A (https=) |
| CA (1) | CA2333869C (https=) |
| DE (1) | DE69937802T2 (https=) |
| DK (1) | DK1112062T3 (https=) |
| ES (2) | ES2299258T3 (https=) |
| NZ (1) | NZ508259A (https=) |
| PT (1) | PT1112062E (https=) |
| WO (1) | WO2000015193A1 (https=) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9504265D0 (en) | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
| AUPO983897A0 (en) | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
| AUPP310798A0 (en) | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
| FR2761600B1 (fr) * | 1998-06-19 | 2000-03-31 | Oreal | Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant |
| AUPP583198A0 (en) * | 1998-09-11 | 1998-10-01 | Soltec Research Pty Ltd | Mousse composition |
| US8263580B2 (en) | 1998-09-11 | 2012-09-11 | Stiefel Research Australia Pty Ltd | Vitamin formulation |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| JP2003012501A (ja) * | 2001-06-27 | 2003-01-15 | Rohto Pharmaceut Co Ltd | 鎮痒エアゾール製剤 |
| US20050129722A1 (en) * | 2002-03-13 | 2005-06-16 | Collagenex Pharmaceuticals, Inc. | Water-based delivery systems |
| AU2003233396B2 (en) * | 2002-03-13 | 2007-05-24 | Thomas Skold | Water-based delivery systems |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US20050271596A1 (en) * | 2002-10-25 | 2005-12-08 | Foamix Ltd. | Vasoactive kit and composition and uses thereof |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US20060233721A1 (en) * | 2002-10-25 | 2006-10-19 | Foamix Ltd. | Foam containing unique oil globules |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| ES2532906T5 (es) * | 2002-10-25 | 2022-03-23 | Foamix Pharmaceuticals Ltd | Espuma cosmética y farmacéutica |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US7700076B2 (en) * | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US20080031907A1 (en) * | 2002-10-25 | 2008-02-07 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US8119150B2 (en) * | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US9668972B2 (en) * | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| ES2637956T3 (es) | 2003-01-24 | 2017-10-18 | Stiefel Research Australia Pty Ltd | Espuma farmacéutica |
| US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
| WO2004100918A1 (ja) * | 2003-05-13 | 2004-11-25 | The Nisshin Oillio, Group, Ltd. | 水中油型乳化化粧料 |
| US7186416B2 (en) | 2003-05-28 | 2007-03-06 | Stiefel Laboratories, Inc. | Foamable pharmaceutical compositions and methods for treating a disorder |
| JP4615198B2 (ja) * | 2003-07-25 | 2011-01-19 | 久光製薬株式会社 | 抗真菌エアゾール外用製剤 |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| EP2977043A3 (en) * | 2003-08-25 | 2016-04-06 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
| CA2548892C (en) * | 2003-12-12 | 2015-10-27 | Eran Eilat | Compositions for treatment of ear disorders and methods of use thereof |
| US8940321B2 (en) | 2003-12-12 | 2015-01-27 | Otic Pharma Ltd. | Compositions for treatment of ear disorders and methods of use thereof |
| AU2005201455A1 (en) * | 2004-02-04 | 2005-08-25 | Foamix Ltd. | Cosmetic and pharmaceutical foam with solid matter |
| US8697712B2 (en) * | 2004-04-05 | 2014-04-15 | Laboratorios Liomont, S.A. De C.V. | Presentation of an antiviral pharmaceutical composition |
| WO2007039825A2 (en) * | 2005-05-09 | 2007-04-12 | Foamix Ltd. | Saccharide foamable compositions |
| US9173835B2 (en) | 2005-05-10 | 2015-11-03 | Dermipsor Ltd. | Compositions and methods for treating hyperproliferative epidermal diseases |
| US20060264344A1 (en) * | 2005-05-23 | 2006-11-23 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Mild foaming cleansing composition |
| EP2526930B1 (en) * | 2005-06-01 | 2013-12-25 | GlaxoSmithKline Intellectual Property Development Limited | Vitamin formulation |
| CN101340884A (zh) | 2005-10-19 | 2009-01-07 | 曼尼·马纳舍·辛格尔 | 用于治疗多汗症的方法 |
| EP2010133B1 (en) | 2006-03-31 | 2016-05-04 | Stiefel Research Australia Pty Ltd | Foamable suspension gel |
| WO2008008397A2 (en) * | 2006-07-14 | 2008-01-17 | Stiefel Research Australia Pty Ltd | Fatty acid pharmaceutical foam |
| WO2009007785A2 (en) * | 2006-11-14 | 2009-01-15 | Foamix Ltd. | Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| AR066901A1 (es) * | 2007-05-18 | 2009-09-23 | Alcon Mfg Ltd | Composiciones fodfolipidicas para elcuidado de lentes de contacto y conservacion de composiciones farmaceuticas |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| EP2242476A2 (en) | 2008-01-14 | 2010-10-27 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| TW201010727A (en) * | 2008-09-03 | 2010-03-16 | Alcon Res Ltd | Pharmaceutical composition having relatively low ionic strength |
| PT2400951T (pt) | 2009-02-25 | 2018-11-26 | Mayne Pharma Llc | Composições de espuma tópica |
| FR2943914A1 (fr) * | 2009-04-06 | 2010-10-08 | Fabre Pierre Dermo Cosmetique | Flacon mousseur comprenant une composition pharmaceutique |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| PL2335675T3 (pl) | 2009-12-10 | 2015-08-31 | Neubourg Skin Care Gmbh & Co Kg | Wolne od emulgatorów, stabilizowane polimerem formulacje pianki |
| WO2011130455A1 (en) | 2010-04-13 | 2011-10-20 | Najib Babul | Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use |
| KR101749514B1 (ko) | 2010-06-11 | 2017-06-21 | 레오 파마 에이/에스 | 비타민 ｄ 유사체 및 코르티코스테로이드를 포함하는 약제학적 분무 조성물 |
| US9724324B2 (en) | 2011-07-20 | 2017-08-08 | Perrigo Israel Pharmaceuticals Ltd. | Topical oily foam compositions |
| WO2013055774A1 (en) | 2011-10-11 | 2013-04-18 | Fallien Cosmeceuticals, Ltd. | Foamable sunscreen formulation |
| WO2013065051A1 (en) | 2011-11-01 | 2013-05-10 | Naveh Pharma (1996) Ltd. | Formulation and device for treating ceruminosis |
| EP2938327B1 (en) | 2012-12-26 | 2017-12-06 | Otic Pharma Ltd. | Foamable otic pharmaceutical compositions |
| WO2015123238A1 (en) * | 2014-02-14 | 2015-08-20 | Mission Pharmacal Company | Stabilized, sprayable emulsion containing active agent particles |
| AU2015217274B2 (en) | 2014-02-14 | 2019-07-25 | Mission Pharmacal Company | Sprayable composition containing zinc oxide and a fluoro-olefin propellant |
| ES2755368T3 (es) | 2014-02-14 | 2020-04-22 | Mission Pharma Co | Dispositivo de suministro por aspersión |
| EP3122325B1 (fr) | 2014-03-28 | 2018-10-31 | Galderma Research & Development | Mousse chimique non rincée contenant du peroxyde de benzoyle |
| US9265727B1 (en) | 2015-01-14 | 2016-02-23 | Delcor Asset Corporation | Spray foam corticosteroid product |
| US10406088B2 (en) | 2015-01-20 | 2019-09-10 | TetraDerm Group LLC | Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration |
| WO2016153946A1 (en) | 2015-03-24 | 2016-09-29 | The Procter & Gamble Company | Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin |
| FR3041537B1 (fr) | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee. |
| FR3041536B1 (fr) | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne. |
| FR3041535B1 (fr) | 2015-09-29 | 2019-01-25 | Galderma Research & Development | Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose. |
| FR3041541B1 (fr) | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee comprenant de l'ivermectine |
| FR3041539B1 (fr) * | 2015-09-29 | 2018-10-26 | Galderma Research & Development | Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis. |
| FR3041538B1 (fr) * | 2015-09-29 | 2018-11-30 | Galderma Research & Development | Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis. |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| WO2020223093A1 (en) | 2019-04-30 | 2020-11-05 | Bayer Healthcare Llc | Topical analgesic gel compositions |
| US12097186B2 (en) | 2019-04-30 | 2024-09-24 | Bayer Healthcare Llc | Topical analgesic compositions |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3330730A (en) * | 1962-08-03 | 1967-07-11 | Colgate Palmolive Co | Pressurized emulsion quick breaking foam compositions |
| US3829563A (en) * | 1972-11-30 | 1974-08-13 | Hoffmann La Roche | Emollient cleansing compositions |
| LU71012A1 (https=) * | 1974-09-26 | 1976-08-19 | ||
| FR2350095A1 (fr) * | 1976-05-03 | 1977-12-02 | Oreal | Compositions destinees a la coloration de la peau a base de derives de la pyridine |
| US4185100A (en) * | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
| US4317817A (en) * | 1979-08-27 | 1982-03-02 | Richardson-Merrell Inc. | Novel steroid 5α-reductase inhibitors |
| US4267173A (en) * | 1979-11-05 | 1981-05-12 | Schering Corporation | Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor |
| US4305936A (en) * | 1980-10-09 | 1981-12-15 | Dermik Laboratories | Topical corticosteroid formulations |
| US4631064A (en) * | 1982-06-01 | 1986-12-23 | The Proctor & Gamble Company | Depilatory compositions |
| US4618344A (en) * | 1982-06-01 | 1986-10-21 | The Procter & Gamble Company | Depilatory compositions |
| GB8315787D0 (en) * | 1983-06-08 | 1983-07-13 | Briggs J H | Coolant spray |
| US4607028A (en) * | 1983-08-18 | 1986-08-19 | Ciba-Geigy Corporation | Novel carboxylic acid esters |
| CA1272953A (en) * | 1984-10-08 | 1990-08-21 | Yuji Makino | Pharmaceutical composition for external use containing active-type vitamin d.sub.3 |
| GB2172298B (en) * | 1985-03-01 | 1988-11-23 | Procter & Gamble | Mild detergent mousse |
| US4847068A (en) * | 1987-08-06 | 1989-07-11 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions |
| US4981677A (en) * | 1987-09-23 | 1991-01-01 | L'oreal | Petrolatum-containing aerosol foam concentrate |
| JPH01156906A (ja) * | 1987-09-23 | 1989-06-20 | L'oreal Sa | スキンコンデイショニングエアゾールフオーム組成物 |
| US5143717A (en) | 1987-12-30 | 1992-09-01 | Code Blue Medical Corporation | Burn foam and delivery system |
| US4992478A (en) * | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| CA2042583C (en) * | 1989-07-28 | 1995-06-20 | Akira Nakagawa | Foamable aerosol preparation |
| US5037655A (en) * | 1990-04-18 | 1991-08-06 | Giovanoni Richard L | Method of stabilizing tretinoin |
| US5167950A (en) * | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
| US5252331A (en) * | 1992-03-05 | 1993-10-12 | Lorenzo Freeman | Less irritating shaving material |
| WO1994013257A1 (en) * | 1992-12-16 | 1994-06-23 | Creative Products Resource Associates, Ltd. | Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder |
| US5420106A (en) * | 1994-03-22 | 1995-05-30 | Bristol-Myers Squibb Company | Method and composition having enhanced alpha-hydroxy acid skin permeation and retention |
| AU2068895A (en) * | 1994-03-24 | 1995-10-09 | Ciba-Geigy Ag | Dl- di- or tri-hydroxyphenylglycine alkyl esters for the treatment of inflammatory and allergic conditions |
| US5976555A (en) * | 1994-09-07 | 1999-11-02 | Johnson & Johnson Consumer Products, Inc. | Topical oil-in-water emulsions containing retinoids |
| GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
| EP0738510A3 (fr) * | 1995-04-20 | 2005-12-21 | L'oreal | Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes |
| US5902805A (en) * | 1996-04-22 | 1999-05-11 | L'oreal | Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same |
| DE19631221C2 (de) * | 1996-08-02 | 1999-07-01 | Beiersdorf Ag | Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen |
| US6008254A (en) * | 1997-05-09 | 1999-12-28 | Kligman; Douglas E. | Method of treating skin disorders with high-strength tretinoin |
| GB2327344A (en) * | 1997-07-18 | 1999-01-27 | Ninh Thuy On | Pharmaceutical compositions containing phenytoin and either an azole anti-fungal/anti-bacterial agent and/or a silver salt for topical application |
| US5965500A (en) * | 1997-07-24 | 1999-10-12 | Levers Brothers Company, Division Of Conopco, Inc. | Stable liquid composition comprising high levels of emollients |
| PT1014916E (pt) * | 1997-08-18 | 2002-06-28 | Neubourg Stephanie | Espuma creme de proteccao dermatologica |
| US6075056A (en) * | 1997-10-03 | 2000-06-13 | Penederm, Inc. | Antifungal/steroid topical compositions |
| AUPP583198A0 (en) * | 1998-09-11 | 1998-10-01 | Soltec Research Pty Ltd | Mousse composition |
| CA2530407A1 (en) * | 2003-07-23 | 2005-02-03 | The Regents Of The University Of California | Penetration enhancer combinations for transdermal delivery |
| FR2871696B1 (fr) * | 2004-06-17 | 2006-11-10 | Galderma Sa | Composition topique pour le traitement du psoriasis |
-
1998
- 1998-09-11 AU AUPP5831A patent/AUPP583198A0/en not_active Abandoned
-
1999
- 1999-09-08 PT PT99947098T patent/PT1112062E/pt unknown
- 1999-09-08 AU AU60692/99A patent/AU760153B2/en not_active Expired
- 1999-09-08 BR BR9913154-4A patent/BR9913154A/pt not_active Application Discontinuation
- 1999-09-08 EP EP99947098A patent/EP1112062B1/en not_active Expired - Lifetime
- 1999-09-08 US US09/719,662 patent/US6730288B1/en not_active Expired - Lifetime
- 1999-09-08 EP EP07118237.2A patent/EP1872776B1/en not_active Expired - Lifetime
- 1999-09-08 JP JP2000569777A patent/JP4603164B2/ja not_active Expired - Lifetime
- 1999-09-08 ES ES99947098T patent/ES2299258T3/es not_active Expired - Lifetime
- 1999-09-08 AT AT99947098T patent/ATE381315T1/de active
- 1999-09-08 NZ NZ508259A patent/NZ508259A/en not_active IP Right Cessation
- 1999-09-08 WO PCT/AU1999/000735 patent/WO2000015193A1/en not_active Ceased
- 1999-09-08 ES ES07118237T patent/ES2431330T3/es not_active Expired - Lifetime
- 1999-09-08 DK DK99947098T patent/DK1112062T3/da active
- 1999-09-08 CA CA002333869A patent/CA2333869C/en not_active Expired - Lifetime
- 1999-09-08 DE DE69937802T patent/DE69937802T2/de not_active Expired - Lifetime
-
2004
- 2004-01-27 US US10/766,202 patent/US7029659B2/en not_active Expired - Lifetime
-
2005
- 2005-12-16 US US11/303,298 patent/US20060104912A1/en not_active Abandoned
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
| US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
| US8992896B2 (en) | 2009-10-02 | 2015-03-31 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002524490A5 (https=) | ||
| JP4557310B2 (ja) | コルチコステロイド含有薬物組成物 | |
| JP4603164B2 (ja) | ムースの組成 | |
| US20070196323A1 (en) | Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs | |
| US20070189977A1 (en) | Spray-on formulations and methods for dermal delivery of drugs | |
| AU2010226476B2 (en) | Fatty acid monoglyceride compositions | |
| US20070196458A1 (en) | Compositions and methods for dermally treating neuropathic pain | |
| CA2444533C (en) | Pharmaceutical vehicle | |
| US20070190124A1 (en) | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs | |
| WO2005087195A3 (en) | Novel compositions for topical delivery | |
| US20100029602A1 (en) | Low-dose mometasone formulations | |
| JP2009519958A (ja) | 薬物の皮膚送達のための、フラックス化可能な組成物および方法 | |
| WO2018138737A1 (en) | Therapeutic topical compositions of apremilast | |
| CA2633515A1 (en) | Compositions and methods for dermally treating pain | |
| CN100431531C (zh) | 包含vp/va共聚物和非水性载体的透皮喷雾药物组合物 | |
| WO2007070694A2 (en) | Spray-on formulations and methods for dermal delivery of drugs | |
| CA2747845A1 (en) | Compositions and methods for dermally treating pain | |
| CA2756674A1 (en) | Microemulsion & sub-micron emulsion process & compositions | |
| US20190358160A1 (en) | Sub-micron emulsions | |
| AU2014326221A1 (en) | Propellant-free topical spray composition of halobetasol | |
| KR20180128450A (ko) | 글리코피롤레이트의 국소 스프레이 포뮬레이션 | |
| KR100810404B1 (ko) | 알프로스타딜 알킬 에스테르를 함유하는 외용제 조성물 | |
| CZ269293A3 (en) | Medicinal ointment without skin irritating effect and process for preparing thereof |